Says Stan Rosenfeld, the group’s leader, the award was, “well deserved recognition for his invaluable contributions to the prostate cancer community.”
News & Highlights
from October 2019
Sima Porten, MD, MPH was selected as one of the final seven proposals to receive OptumLabs-funded access to its database of de-identified, linked clinical and administrative claims information.
Dr. Suskind is being recognized for her cumulative work in the area of female urologic issues in frail older adults. She will receive the award during the February SUFU annual meeting.
Circulating tumor cells (CTCs) are cells shed by primary or disseminated tumors. They are easily obtained with a peripheral blood draw and therefore allow for a minimally invasive way to monitor tumor progression.
Filter By Topic
Filter by Date
Agree! Great Q&A with Dr. Ruggero the recent UCSF Helen Diller Family Comprehensive Cancer Center newsletter… t.co/7etg6aGeqh
Dr Carroll et al in @CancerMed on, "Development and pilot evaluation of a personalized decision support interventio… t.co/RN9UDg3bhN
Dr. Breyer et al in @CurrUrolRep on, "Female Urethral Strictures: Review of Diagnosis, Etiology, and Management" t.co/D2q8PeXfKY
Dr Westphalen et al in @RadiolBras on, "Differences in negative predictive value of prostate MRI based in men with… t.co/c4ZMWMMzB8
Dr Baskin et al in @Differentiation on, "Imaging the developing human external and internal urogenital organs with… t.co/0ZPcPZKiDu
Dr Carroll et al in @CanJUrol on, "Germline testing in those at risk of prostate cancer." t.co/p3EoVJ0dFR
Congratulations to Dr. Carroll for receiving Société Internationale d’Urologie SIU-Mostafa M. Elhilali Award "in re… t.co/o2Lc2Lnt3K
Drs Cunha, Baskin et al in @Differentiation on, "Reproductive tract biology: Of mice and men" t.co/uudxAAkz3c